Background: The use of serological assays for diagnosis of bovine tuberculosis (TB) has been intensively studied and use of specific antigens have aided in improving the diagnostic accuracy of the assays. In the present study, we report an in-house enzyme linked immunosorbent assay (ELISA), developed by using ethanol extract of Mycobacterium bovis (M. bovis). The assay, named (ethanol vortex ELISA [EVELISA]), was evaluated for detection of anti-M. bovis antibodies in the sera of cattle and white-tailed deer.
Background
Mycobacterium bovis (M. bovis), a member of the Mycobacterium tuberculosis complex, causes bovine tuberculosis (TB) [1, 2] , a zoonotic disease of animals including livestock, alternative livestock (e.g., captive cervids), zoo and wildlife. The major wildlife reservoirs of M. bovis include Eurasian badger (Meles meles), brushtail possums (Trichosurus vulpecula), Eurasian wild boar (Sus sucrofa) and white-tailed deer (Odocoileus virginianus). For many developed nations, difficulties in eradicating bovine TB often arise due to the presence of infection in wildlife reservoirs with spillover to domestic species and movement of infected animals to bovine TB free regions. Within the US, eradication of bovine TB is hampered by importation of TB cattle from Mexico, the presence of a wildlife reservoir (i.e., white-tailed deer in Michigan), and continued detection of small nests of infection within the domestic herd. Particularly problematic for antemortem testing strategies is the detection of bovine TB in a very small number of animals in large dairy herds.
Bovine TB control relies primarily on detection of TBaffected herds by slaughter surveillance and antemortem testing. While current testing strategies are generally reliable at the herd level, the development of new diagnostic strategies for effective control of bovine TB is urgently needed, particularly for movement or border tests to identify individual infected animals [3] . In a recent report from the United States Animal Health Association, a key recommendation to USDA, APHIS, Veterinary Services was to assist biologics companies in the development and evaluation of improved bovine TB diagnostic tests, emphasizing both stakeholder and federal government support for the development of improved bovine TB testing strategies [4] .
The diagnostic assays currently available for detection of bovine TB in cattle and wildlife species could be divided mainly into 2 categories; direct assays (i.e. bacterial culture, microscopic demonstration of acid-fast bacilli and polymerase chain reaction [PCR]) and indirect assays (i.e. detection of cellular or humoral immune response) [5, 6] . Among the direct assays, bacterial culture and PCR are primarily used as postmortem tests as these tests lack the necessary sensitivity for antemortem detection of TB-infected animals and generally rely on detection of the organism within samples collected at necropsy. Cell mediated immune-based assays primarily include the tuberculin skin test (TST) [7] and interferon gamma (IFN-γ) release assays [8, 9] , although other strategies are under development [10] . In spite of advantages like simplicity of the procedure and comparatively inexpensive reagents, the TST is very labor intensive; requires two visits to the farm (i.e., injection of tuberculin and evaluation of the response 72 hours later) and practically difficult for wildlife species. IFN-γ release assays are comparatively expensive; require overnight delivery of viable blood samples and a trained technical staff [11] . Antibody-based assays for detection of bovine TB have shown promising results due to their short turnaround time, cost effectiveness and flexibility of use. Previous studies used cross-reactive antigens and suffered from lower diagnostic specificity. The emergence of sensitive antibody-based diagnostic tests for detection of bovine TB supports the concept of development of a reliable and easy to use serologic test [12] [13] [14] [15] [16] .
We have previously reported an enzyme linked immunosorbant assay (ELISA) using ethanol extract of Mycobacterium avium subsp. paratuberculosis (MAP) to detect anti-MAP antibodies at early stage of Johne's disease and named the assay ethanol vortex ELISA (EVELISA) [17] [18] [19] [20] [21] . We also reported an EVELISA based assay for detection of specific antibodies in the sera of farmed red deer [22] . The objective of the present study was to determine the potential for application of the EVELISA test to detect anti-M. bovis antibodies in the sera of infected cattle and free-ranging white-tailed deer.
Methods

Cattle samples
A total of 62 sera samples from cattle were obtained from the TB serum bank at US Department of Agriculture -Animal and Plant Health Inspection Service. The samples were obtained from farms in three states in the U.S.: Georgia (n = 40; dairy), Michigan (n = 21; beef ) and California (n = 1; dairy). All the samples from Georgia were from a bovine TB-free herd whereas the California and Michigan samples were from M. bovis-infected cattle, as determined by mycobacterial culture, histology and IS6110 PCR techniques (performed at the National Veterinary Services Laboratories, Ames, IA). The 22 samples from Michigan and California received M. bovis PPD for Caudal Fold Test (CFT). All the 62 samples in this group were also tested for quantification of cellular immune response using IFN-γ assay and comparative cervical tuberculin (CCT) test. The CCT test involves injection of both M. bovis and M. avium PPD at 2 different sites on the neck. Serum samples were obtained before or at the time of injection of PPDs for skin testing. Of the total animals tested, 2 and 1 animals were categorized as suspected with CFT and CCT, respectively.
Deer samples
A total of 41 serum samples from white-tailed deer were obtained from the USDA/APHIS. Twenty five samples were from uninfected animals, 7 samples were from naturally infected animals from Michigan and 9 samples were from animals which were experimentally infected with M. bovis as previously described in Waters et al., 2004 [23] .
Preparation of ethanol extract
A virulent strain of M. bovis (HC2005T), which was originally isolated from an M. bovis infected dairy cow, was cultured in Middlebrook's 7H9 medium (Becton Dickinson, Cockeysville, MD) with addition of 0.05% Tween 80 (Fisher Scientific, Fair Lawn, NJ), 10% oleic acid-albumin-dextrose-NaCl (Becton Dickinson, Microbiology Systems, Franklin Lakes, NJ) at 37°C. For antigen preparation, M. bovis bacilli was harvested from stationary phase cultures, suspended in 80% ethanol at 80 mg wet weight of bacterial/ml and agitated by vortex at room temperature for 2 min, and centrifuged at 10,621 × g for 10 minutes to dislodge surface antigens. Extracted M. bovis antigen was diluted (1:80) in the ethanol solution and 50 μL of the solution was immobilized on wells of a 96-well microtiter plate (Costar™, Corning, MA) by evaporation. 
Thin layer chromatography
The ethanol extract was dried by spinning in a speed vacuum concentrator (Thermo Fisher Scientific Inc., Waltham, MA) and washed with a mixture of 1 mL of chloroform/methanol (2:1) and 200 μL of water. The organic layer was transferred to a new tube and dried. The extract was then re-suspended in a chloroform/methanol (2:1) solution at the concentration of 5 mg/mL and separated by thin layer chromatography on an aluminum-backed Silica gel plate (TLC Silica gel 60, Merck KGaA, Darmstadt, Germany) with a development solution (chloroform/methanol/water [90:10:1]). The Silica gel plates were then stained using a polymolybdate solution.
Western blotting
To determine if M. bovis specific immunodominant antigen, MPB83, was present in M. bovis ethanol extracts, a Western blot using monoclonal antibody against MPB83 (1 F11, kind gift from Dr. Jim McNair, Agri-Food Biosciences Institute, Northern Ireland) was conducted. The extract (~10 μg) and recombinant protein (7 μg) were mixed 1:1 with 2× SDS-PAGE loading dye and loaded onto a 12% (w/v) SDS-PAGE gel for electrophoretic separation. Electro-transfer of proteins onto pure nitrocellulose was accomplished with the Bio-Rad Trans Blot Cell (Bio-Rad Laboratories) with sodium phosphate buffer (25 mM, pH 7.8) at 0.8 A for 90 min. After transfer, nitrocellulose was blocked with phosphate-buffered saline (PBS; 150 mM NaCl, 10 mM NaPO4, pH 7.4) plus 2% bovine serum albumin (BSA) and 0.1% Tween-20 (block buffer). Monoclonal antibody was diluted 1:500 in block buffer and incubated on the blot at room temperature for 2 h. After three washes in PBS plus 0.1% Tween-20, blots were incubated for 1.5 h in anti-mouseperoxidase (Thermo Scientific) diluted 1:20,000 in block buffer. The blots were again washed three times as described above and developed using SuperSignal West Pico chemiluminescent substrate (Thermo Scientific).
Statistical analysis
All experiments were conducted in duplicate or triplicate, and repeated at least twice. The test sensitivity was determined by dividing the number of M. bovis culturetest positive animals by the total number of M. bovis culture positive animals, with the result expressed as a percentage. The test specificity was determined by dividing the number of bTB free, test-negative animals by the total number of bTB free animals, with the result expressed as a percentage. The cut-off value was determined based on the two-graph receiver operating characteristic (ROC) analysis [24] .
Ethical approval
All animal care and use procedures were reviewed and approved by the NADC Animal Care and Use Committee.
Results and discussion
A total of 62 serum samples from uninfected (n = 40) and M. bovis infected (n = 22, natural infection) beefdairy cattle were used to test in the EVELISA format to detect anti-M. bovis antibodies ( Figure 1A) . Thirtyseven (92.5%) of the M. bovis uninfected animals which were obtained from TB-free herds showed lower levels of antibody binding than the tentative cut-off value of 0.4. Of the 22 serum samples obtained from bovine TB positive animals, 17 samples (77.3%) showed higher antibody binding than the cut-off. Of the 5 bovine TB positive animals with antibody binding lower than the cut-off, three animals had negative IFN-γ assay results and the other two had CCT "suspect" test results. Forty one serum samples from deer were tested to detect the level of anti-M. bovis antibodies in EVELISA format ( Figure 1B) . All of the samples from uninfected animals (n = 25) showed a lower level of antibody binding than the tentative cut-off value of 0.068. The cutoff value as determined by ROC analysis was much lower than that of cattle, which may be due to lower antibody titer in deer than in cattle or lower affinity of anti-deer IgG secondary antibody than that of anti-bovine IgG antibody. All the samples from the bovine TB positive deer except 1 animal each in the naturally (n = 7) and experimentally (n = 9) infected groups showed higher levels of antibody binding than the cut-off. In this study, M. phlei was used to preabsorb cross-reactive antibodies in the serum samples. The preabosorption improved accuracy of EVELISA when compared to that of EVELISA with noabsorption (data not shown). However, the cause of crossreactive antibodies in EVELISA with no-absorption is not known. The presence of M. bovis -specific molecules in the ethanol extract of M. bovis was analyzed by thin layer chromatography (TLC) and Western blotting. The TLC lipid analysis suggested the presence of three M. bovis -specific lipids in the extract after staining with polymolybdate solution (Figure 2A ; Lane 1, Arrows) when compared with lipid profile of ethanol extracts from MAP (K10 Strain), MAP (Linda Strain) and M. avium subsp. avium (Figure 2A; Lane 2, 3 and 4 ). By Western blot analysis, MPB83 was detected in the ethanol extract ( Figure 2B ). Since MPB83 was shown to be antigenic and react with antibodies in M. bovis -infected animals, it is likely that the molecule was contributing to the antibody reaction in the EVELISA test used in this study. On the other hand, the specific molecules detected by TLC may not have contributed to the antibody reaction in EVELISA because antibody reaction was low when chloroform-extractable fraction of the ethanol extract was tested in an ELISA format (data not shown).
Recent advances with use of M. bovis specific proteins such as MPB83, MPB70, ESAT-6, and CFP-10 have improved the specificity of serologic-based assays; however, with only minimal improvement of sensitivity [5] . Several studies have used these antigens and evaluated diagnostic sensitivity and specificity. For example, De Anda et al., 1996 reported a sensitivity of 73% using MPB70 in an ELISA format to test 120 M. bovis infected and 223 cattle from bovine TB free herd [25] . Waters et al., 2011 tested MPB83 and MPB70 using sera from infected cattle and reported apparent sensitivity and specificity of 63% and 98%, respectively [16] . ESAT-6 and CFP-10 were used in an ELISA format by Whelan et al., 2008 using a total of 1489 bovine TB negative and 522 bovine TB positive cattle sera and stated sensitivity of 40.6% -86.6% and specificity of 82.6% -69.7%, based upon use of two different test interpretation criteria [26] . In the present study, we detected anti-M. bovis antibodies in 77.2% and 87.5% infected cattle and deer, respectively. However, the number of samples in this study is not enough to compare diagnostic accuracy and there is a need to test more samples to further validate the EVELISA for use in the diagnosis of bovine TB.
Conclusions
Control activities for bovine TB are being regularly discussed by the regulatory agencies since the organism has been recognized as a threat to the One Health triad (human-livestock-wildlife). Serological assays with their logistics and financial advantages have proved to fit very well in the strategy for controlling bovine TB. Our data indicated that EVELISA test may have a diagnostic sensitivity comparative with ELISA tests reported previously and warrant further studies using a larger number of samples to validate the accuracy of the test. We recently showed that serodiagnosis of Johne's disease with ethanol extract of MAP can be done in two minutes by a capacitance biosensor which may be a potential format for development of an on-site test for bovine TB using the M. bovis extract [27, 28] . 
